Pharmeasy has determined the Conversion Price of the CCPS Series-A

20 September 2023

The company has determined the CCPS Series-A Conversion Price in accordance with the terms and conditions mentioned in a resolution passed by the Board meeting dated May 15, 2023, at ₹ 4.356 per share, which corresponds to a maximum of up to 125,88,32,279 equity shares to be issued upon the conversion of CCPS-A.